Neoplasms / turse

Methods for avoiding edema in the treatment or prevention of PPAR.gamma.-responsive diseases, including cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT Not Applicable REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED ON A COMPACT DISK Not Applicable BACKGROUND OF THE INVENTION Peroxisome proliferator-activated

Vinpocetine for pulmonary hemorrhage and edema

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION (a) Field of the Invention This invention relates to a novel therapeutic use of apovincaminic acid ethyl ester. More specifically this invention relates to a method for inhibiting pulmonary hemorrhage and edema associated with intracranial syndromes such as trauma, tumor,

2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-.alpha. and neuroprotector of brain in closed head injury

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION 1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF-.alpha.), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in

Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

INTRODUCTION This invention relates to the medical treatment of victims of cerebral edema, and especially to the relief of brain swelling as a result of ischemic strokes especially, but also swelling due a to tumors, surgeries, or cerebral trauma, which swelling usually results in severe disability

Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

Substituted-3- (2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-dione s for treatment of grey matter edema

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-dione s, for treatment of grey matter edema

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

Therapeutic use of acetazolamide for the treatment of brain edema

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

This invention relates to the medical treatment of victims of cerebral edema, and especially to the relief of brain swelling as a result of ischemic strokes especially, but also swelling due to tumors, surgeries, or cerebral trauma, which swelling usually results in severe disability and often death

Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The invention relates to the field of pathological angiogenesis and arteriogenesis. In particular, the invention describes a stress-induced phenotype in a transgenic mouse (PIGF-) that does not produce Placental Growth Factor (PIGF) and that demonstrates an impaired vascular

Substituted amidinoalkoxy and amidinoalkylamino indanones and salts thereof

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, the neurological problems caused by AIDS, cerebral

Substituted (2,3-dihydro-1-oxo-1H-inden-5-yl)alkanoic acids, their derivatives and their salts

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

Substituted [(2,3-dihydro-1-oxo-1H-inden-5-yl)amino]alkanoic acids, their derivatives and their salts

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

2,3-dihydro-5-(3-oxo-2-cyclohexen-1-yl)-2-benzofurancarboxylic acids, and their salts useful in the treatment of brain injury

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Trauma to the brain or spinal cord caused by physical forces acting on the skull or spinal column, by ischemic stroke, arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, encephalomyelitis, hydrocephalus,

neoplasms/turse

Methods for avoiding edema in the treatment or prevention of PPAR.gamma.-responsive diseases, including cancer

Vinpocetine for pulmonary hemorrhage and edema

2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-.alpha. and neuroprotector of brain in closed head injury

Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema

Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones

Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema

Substituted-3- (2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema

Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-dione s for treatment of grey matter edema

Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-dione s, for treatment of grey matter edema

Therapeutic use of acetazolamide for the treatment of brain edema

Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage

Substituted amidinoalkoxy and amidinoalkylamino indanones and salts thereof

Substituted (2,3-dihydro-1-oxo-1H-inden-5-yl)alkanoic acids, their derivatives and their salts

Substituted [(2,3-dihydro-1-oxo-1H-inden-5-yl)amino]alkanoic acids, their derivatives and their salts

2,3-dihydro-5-(3-oxo-2-cyclohexen-1-yl)-2-benzofurancarboxylic acids, and their salts useful in the treatment of brain injury

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus